Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
Background: Prostate cancer has a multifaceted treatment pattern. Evidence is lacking for optimal treatment sequences for metastatic castration-resistant prostate cancer (mCRPC). Objective: To increase the understanding of real-world treatment pathways and outcomes in patients with mCRPC. Design, se...
Main Authors: | Anders Bjartell, Luis Costa, Gero Kramer, Bogdan Zurawski, Luca Galli, Patrick Werbrouck, Thorsten Ecke, Omi Parikh, Mostefa Bennamoun, Camilo Garcia Freire, Avivit Peer, Börje Ljungberg, Irfan Cicin, Emma Smith, Martin Lukac, Robert Wapenaar, Simon Chowdhury |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | European Urology Open Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168322008886 |
Similar Items
-
Treatment sequencing in metastatic castrate-resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2014-06-01) -
New developments in the treatment of castration resistant prostate cancer
by: Roxanne Wadia, et al.
Published: (2014-08-01) -
Splice variants of androgen receptor and prostate cancer
by: Orazio Caffo, et al.
Published: (2016-05-01) -
Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgen-signaling-targeted inhibitor resistance
by: Peng-Fei Zhang, et al.
Published: (2021-01-01) -
Renal and Cardiovascular Toxicities by New Systemic Treatments for Prostate Cancer
by: Giuseppe Saltalamacchia, et al.
Published: (2020-07-01)